1.
Front Public Health
; 5: 208, 2017.
Artículo
en Inglés
| MEDLINE
| ID: mdl-29021977
RESUMEN
On March 24 and 25, 2017 researchers and clinicians from around the world met at Temple University in Philadelphia to discuss the current knowledge of Mycobacterium avium ssp. paratuberculosis (MAP) and its relationship to human disease. The conference was held because of shared concern that MAP is a zoonotic bacterium that poses a threat not only to animal health but also human health. In order to further study this problem, the conferees discussed ways to improve MAP diagnostic tests and discussed potential future anti-MAP clinical trials. The conference proceedings may be viewed on the www.Humanpara.org website. A summary of the salient work in this field is followed by recommendations from a majority of the conferees.
2.
Gastroenterology
; 133(5): 1742; author reply 1745-6, 2007 Nov.
Artículo
en Inglés
| MEDLINE
| ID: mdl-17983825
Asunto(s)
Antibacterianos/uso terapéutico , Enfermedad de Crohn/tratamiento farmacológico , Enfermedad de Crohn/virología , Mycobacterium avium subsp. paratuberculosis/patogenicidad , Paratuberculosis/complicaciones , Claritromicina/uso terapéutico , Clofazimina/uso terapéutico , Quimioterapia Combinada , Humanos , Paratuberculosis/tratamiento farmacológico , Ensayos Clínicos Controlados Aleatorios como Asunto , Rifabutina/uso terapéutico
3.
J Crohns Colitis
; 6(4): 503; author reply 505, 2012 May.
Artículo
en Inglés
| MEDLINE
| ID: mdl-22398089